Vaccines | Free Full-Text | High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events
Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
Konstantinos Stathopoulos - Project Manager - EPIRUS SA – ΗΠΕΙΡΟΣ ΑΕΒΕ | LinkedIn
Nikos Stathopoulos - Greece | Professional Profile | LinkedIn
Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
Microorganisms | Free Full-Text | Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis: Amyloid: Vol 28, No 1
7 "Yannis Stathopoulos" profiles | LinkedIn
PDF) A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
JCM | Free Full-Text | Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study
JCM | Free Full-Text | Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Primary plasma cell leukemia presenting as secondary pulmonary alveolar proteinosis: Leukemia & Lymphoma: Vol 61, No 9
Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis
Spiros Stathopoulos - Civil Engineer - ETHNOKAT | LinkedIn
Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis
IOANNIS STATHOPOULOS - DR. CARDIOLOGY - NHS | LinkedIn
Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
Cancers | Free Full-Text | A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma | HTML
Microorganisms | Free Full-Text | Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection
